Morgan Stanley Sees 67% Upside Potential for Vir Biotechnology Stock
Morgan Stanley has upgraded Vir Biotechnology ( VIR, Financial) and uplifted its price target for the stock to $20 from ...
Daijiworld32m
Goldman Sachs lowers target price of Reliance Industries’ stock, maintains 'Buy'
Global brokerage Goldman Sachs on Thursday lowered its target price for Reliance Industries Ltd (RIL), while maintaining 'buy' rating for the diversified group. The brokerage reduced RIL's target ...